Progesterone receptor agonists and antagonists

被引：6

作者：

Allan, G ^{[1
]}

Macielag, M ^{[1
]}

机构：

[1] RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 1999年 / 9卷 / 07期

关键词：

contraception; endometriosis; leiomyomata; mifepristone; progestin;

D O I：

10.1517/13543776.9.7.955

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Steroidal progestin agonists have long been used in oral contraceptives, and the progestin antagonist mifepristone is used as an abortifacient. Progestin antagonists are also likely to be useful for treating breast cancer and various gynaecological disorders. This patent review relates to progestin receptor agonists and antagonists, focusing on applications filed over the past three years. Two emerging themes will be elaborated upon: the development of novel steroidal and non-steroidal compounds, and the elucidation of new therapeutic uses for progestin antagonists.

引用

收藏

页码：955 / 962

页数：8

相关论文

共 20 条

[1] TREATMENT OF BREAST-CANCER WITH DIFFERENT ANTIPROGESTINS - PRECLINICAL AND CLINICAL-STUDIES [J].

BAKKER, GH ;

SETYONOHAN, B ;

PORTENGEN, H ;

DEJONG, FH ;

FOEKENS, JA ;

KLIJN, JGM .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 37 (06) :789-794

[2] MIFEPRISTONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].

BROGDEN, RN ;

GOA, KL ;

FAULDS, D .

DRUGS, 1993, 45 (03) :384-409

[3] NONSTEROIDAL PROGESTERONE-RECEPTOR LIGANDS .2. HIGH-AFFINITY LIGANDS WITH SELECTIVITY FOR BONE CELL PROGESTERONE RECEPTORS [J].

COMBS, DW ;

REESE, K ;

CORNELIUS, LAM ;

GUNNET, JW ;

CRYAN, EV ;

GRANGER, KS ;

JORDAN, JJ ;

DEMAREST, KT .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4880-4884

[4] NONSTEROIDAL PROGESTERONE-RECEPTOR LIGANDS .1. 3-ARYL-1-BENZOYL-1,4,5,6-TETRAHYDROPYRIDAZINES [J].

COMBS, DW ;

REESE, K ;

PHILLIPS, A .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4878-4879

[5] 5-aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists:: The effect of D-ring substituents [J].

Edwards, JP ;

West, SJ ;

Marschke, KB ;

Mais, DE ;

Gottardis, MM ;

Jones, TK .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (03) :303-310

[6] The effects of self-administering emergency contraception [J].

Glasier, A ;

Baird, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :1-4

[7] Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486) [J].

Kettel, LM ;

Murphy, AA ;

Morales, AJ ;

Yen, SSC .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (06) :1151-1154

[8] SCREENING OF ANTI-PROGESTAGENS BY RECEPTOR STUDIES AND BIOASSAYS [J].

KLOOSTERBOER, HJ ;

DECKERS, GHJ ;

VANDERHEUVEL, MJ ;

LOOZEN, HJJ .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 31 (4B) :567-571

[9]

MICHNA H, 1997, HORM HEALTH DIS, V1, P297

[10] RU-486 (MIFEPRISTONE) - INDUCTION OF DOSE DEPENDENT ELEVATIONS OF ESTRADIOL-RECEPTOR IN ENDOMETRIUM FROM OVARIECTOMIZED MONKEYS [J].

NEULEN, J ;

WILLIAMS, RF ;

HODGEN, GD .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (04) :1074-1075